4.7 Article

The Next Frontier in Sarcoma Care: Digital Health, AI, and the Quest for Precision Medicine

Journal

JOURNAL OF PERSONALIZED MEDICINE
Volume 13, Issue 11, Pages -

Publisher

MDPI
DOI: 10.3390/jpm13111530

Keywords

digital health; artificial intelligence; value-based healthcare; sarcoma; precision medicine; benchmarking; interoperable platforms; quality indicators

Ask authors/readers for more resources

This perspective article explores the opportunities and challenges of leveraging digital health and artificial intelligence in sarcoma care. The authors delineate the current state-of-the-art methodologies and technologies in sarcoma care, and emphasize the need for high-quality data and ethical considerations. The paper concludes with proposals for future research and a call to action for multidisciplinary collaboration and systemic adoption of these technologies.
The landscape of sarcoma care is on the cusp of a transformative era, spurred by the convergence of digital health and artificial intelligence (AI). This perspectives article explores the multifaceted opportunities and challenges in leveraging these technologies for value-based, precision sarcoma care. We delineate the current state-of-the-art methodologies and technologies in sarcoma care and outline their practical implications for healthcare providers, administrators, and policymakers. The article also addresses the limitations of AI and digital health platforms, emphasizing the need for high-quality data and ethical considerations. We delineate the promise held by the synergy of digital health platforms and AI algorithms in enhancing data-driven decision-making, outcome analytics, and personalized treatment planning. The concept of a sarcoma digital twin serves as an illustrative paradigm for this integration, offering a comprehensive, patient-centric view of the healthcare journey. The paper concludes with proposals for future research aimed at advancing the field, including the need for randomized controlled trials or target trial emulations and studies focusing on ethical and economic aspects. While the road to this transformative care is laden with ethical, regulatory, and practical challenges, we believe that the potential benefits far outweigh the obstacles. We conclude with a call to action for multidisciplinary collaboration and systemic adoption of these technologies, underscoring the urgency to act now for the future betterment of sarcoma care and healthcare at large.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available